Crossmark

Durable remission of T cell lymphoblastic lymphoma relapsing after allogeneic haematopoietic stem cell transplantation with a single low dose of nivolumab

Crossref DOI link: https://doi.org/10.1007/s00277-020-04042-1

Published Online: 2020-04-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sim, Joycelyn P. Y.

Lie, Albert K. W.

Ng, Ming-Yen

Kwong, Yok-Lam
License Information

Text and Data Mining valid from 2020-04-21

Version of Record valid from 2020-04-21
More Information

Article History

Received: 10 March 2020

Accepted: 13 April 2020

First Online: 21 April 2020

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: The patient gave informed consent to treatment.

Document is current

Any future updates will be listed below